Navigation Links
Prevagen® is the Number One Branded Memory Supplement in the United States
Date:6/6/2013

Madison, WI (PRWEB) June 06, 2013

Retailers and consumers alike have made Prevagen, the unique brain health supplement shown to improve memory, their preferred memory supplement.

Quincy Bioscience is pleased to announce that Prevagen has won the 2013 Vity Award for the best brain health supplement, for the second time.

The Vity Awards are sponsored by industry leading Vitamin Retailer magazine and honor the top selling vitamins and supplements in each category based on feedback from health food store retailers across the country.

In the chain drug store channel, Prevagen is also number one. Sales data through 2012 from A.C. Nielsen, a global marketing research firm, reveals Prevagen is the best selling branded memory supplement.

“We are very pleased Prevagen remains the preferred memory supplement,” says Quincy Bioscience President Mark Underwood. “Our customers have been telling us how much Prevagen has helped them with thinking, learning, and memory. We are thankful to receive this award confirming their experience.”

Prevagen is the only supplement to contain the breakthrough ingredient ‘apoaequorin’, a protein originally discovered in a jellyfish, and is shown in clinical studies to improve memory.*

As we age, we lose proteins that support our brain. Apoaequorin supplements these proteins during the natural process of aging and can help with mild memory problems associated with aging.*

Prevagen is available in health food stores and pharmacies nationwide. Retailers or consumers interested in learning more about Prevagen can call (888) 814-0814 or visit http://www.prevagen.com.

About Quincy Bioscience
Quincy Bioscience is a biotechnology company based in Madison, Wisconsin, that is focused on the discovery, development and commercialization of novel technologies to support good health in aging. The company’s products focus on supporting memory and cognitive health. Quincy Bioscience is set apart by its cutting-edge applications of the protein apoaequorin, which is breaking new ground in the area of brain health.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10805013.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Prevagen® Now Available Nationwide at Vitamin Shoppe
2. The Second Rarest Job in America: Atlanta Dentist Discusses New Bureau of Labor Statistics that Reveal Low Number of Prosthodontists
3. Mutations in VCP gene implicated in a number of neurodegenerative diseases
4. Victims of Pesticide Misuse to Kill Bed Bugs Rise in Numbers; Spray For Bed Bug Says It's Best to Use Pesticide-Exempt Bed Bug Bully Instead
5. BioSpain 2012 is Larger in Terms of Internationalisation and the Number of Exhibitors, Meetings and Visitors
6. Profil Institute Reports Record Growth in Number of Clinical Trials in the Pipeline
7. Number of Ion Community Users Triples, Spurred by Open Access to DNA Sequencing Protocols and Analysis Software
8. Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice
9. Stem cell transplant restores memory, learning in mice
10. Fantastic flash memory combines graphene and molybdenite
11. Self-assembled nanostructures enable a low-power phase-change memory for mobile electronic devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... 19, 2017  Market Research Future has a half cooked research ... Biopsy is growing rapidly and expected to reach USD 450 Million ... ... Biopsy Market has been assessed as a swiftly growing market and ... in the coming future. There has been a tremendous growth in ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... for pharmaceutical research and development (R&D), today announced the launch of ... and interpretation for the rapidly evolving field of precision medicine. , ...
(Date:1/19/2017)... AquaBounty Technologies, Inc. (AIM: ABTU; NASDAQ: AQB), ... and a majority-owned subsidiary of Intrexon Corporation (NYSE: ... listing of its common shares on the NASDAQ Stock ... "AquaBounty,s listing on NASDAQ represents an important milestone ... the U.S. markets as we advance plans for commercial ...
(Date:1/19/2017)... ... January 19, 2017 , ... DaVita Clinical Research ... drug and device development, and Prism Clinical Research , a leader in ... Verified Clinical Trials (VCT) has been selected by both companies as ...
Breaking Biology Technology:
(Date:1/12/2017)... NEW YORK , Jan. 12, 2017  New research ... around the office of the future.  1,000 participants were simply ... last three months which we may consider standard issue.  Insights ... office of 2017 were also gathered from futurists and industry ... and Dr. James Canton .  Some ...
(Date:1/6/2017)... Calif. , Jan. 6, 2017  Privately-held ... safety studies in healthy volunteers of a novel ... to treat acute pancreatitis. Acute ... typically a mild disorder, but can be very ... failure and sepsis, where extended hospital stays, time ...
(Date:1/4/2017)... 4, 2017  CES 2017 – Valencell , ... today announced the launch of two new versions ... highly-accurate biometric sensor modules that incorporate the best ... and expertise. The two new designs include Benchmark ... hearables, and Benchmark BW2.0, a 2-LED version of ...
Breaking Biology News(10 mins):